
James Chamberlain
Director, Data Analytics and Informatics · George Washington University School of Medicine
Credentials: · ·
History
Research
Racial Disparities in Pain Management of Children With Appendicitis in Emergency Departments
JAMA Pediatrics · 2015 · Last of 5 authors · 386 citations
Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus
New England Journal of Medicine · 2019 · 371 citations
The Lancet · 2020 · First of 20 authors · 174 citations

34 papers

28 papers

20 papers

19 papers

17 papers
- RS
17 papers

16 papers

15 papers
Grants
- 2025–2030
Ketamine Add-On for Established Status Epilepticus Treatment Trial (KESETT)
National Institute of Neurological Disorders and Stroke · UH3
PI · $5.7M · University of Virginia
- 2025–2027
National Institute of Child Health and Human Development · R56
PI · $995.6K · Boston Children's Hospital
- 2025–2026
Ketamine Add-On for Established Status Epilepticus Treatment Trial (KESETT)
National Institute of Neurological Disorders and Stroke · UG3
PI · $9.3M · University of Virginia
- 2014–2020
Established Status Epilepticus Treatment Trial (ESETT)
National Institute of Neurological Disorders and Stroke · U01
PI · $16.3M · University of Virginia
Clinical trials
- 2015–2019
Established Status Epilepticus Treatment Trial
Principal investigator · Completed · Phase 3
University of Virginia
- 2005–2009
Lorazepam for the Treatment of Status Epilepticus in Children
Principal investigator · Completed · Phase 1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)





